The following clinically significant adverse reactions are described elsewhere in the labeling:
1. Gastrointestinal Adverse Reactions
2. QTc Interval Prolongation
3. Hepatotoxicity
4. Interstitial Lung Disease (ILD)/Pneumonitis
FDA,2022.12
Common Side Effects of AdagrasibIn clinical trials, the most common side effects···【more】
Release date:2026-04-22Recommended:23
Serious Side Effects Requiring Immediate Medical AttentionAdagrasib may cause th···【more】
Release date:2026-04-21Recommended:27